Dr. Matthew Dietz
Claim this profilePrimary Children's Hospital
Expert in Tumors
Expert in Neuroblastoma
32 reported clinical trials
61 drugs studied
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Neuroblastoma
Global LeaderMYC positive
Stage IV
MYC negative
Affiliated Hospitals
Clinical Trials Matthew Dietz is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
CBL0137
for Cancer
This trial tests CBL0137, a drug that blocks signals inside cancer cells, in patients whose solid tumors, including CNS tumors or lymphoma, have returned or not responded to treatment. By interfering with the cells' internal communication, the drug aims to stop their growth and cause them to die. CBL0137, also known as Curaxin, has shown antitumor activity in multiple cancers, including glioblastoma, renal cell carcinoma, melanoma, neuroblastoma, and small cell lung cancer.
Recruiting1 award Phase 1 & 213 criteria
More about Matthew Dietz
Clinical Trial Related7 years of experience running clinical trials · Led 32 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Matthew Dietz has experience with
- Cyclophosphamide
- Vincristine
- Carboplatin
- Cisplatin
- Etoposide
- Larotrectinib
Breakdown of trials Matthew Dietz has run
Neuroblastoma
Rhabdomyosarcoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Dietz specialize in?
Matthew Dietz focuses on Tumors and Neuroblastoma. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Matthew Dietz currently recruiting for clinical trials?
Yes, Matthew Dietz is currently recruiting for 11 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Matthew Dietz has studied deeply?
Yes, Matthew Dietz has studied treatments such as Cyclophosphamide, Vincristine, Carboplatin.
What is the best way to schedule an appointment with Matthew Dietz?
Apply for one of the trials that Matthew Dietz is conducting.
What is the office address of Matthew Dietz?
The office of Matthew Dietz is located at: Primary Children's Hospital, Salt Lake City, Utah 84113 United States. This is the address for their practice at the Primary Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.